Follicle Activation by Inhibition of the Hippo Pathway

Sponsor
Anders Nyboe Andersen (Other)
Overall Status
Completed
CT.gov ID
NCT02792569
Collaborator
(none)
20
1
2
33
0.6

Study Details

Study Description

Brief Summary

The aim of this project is to activate recruitment and growth of resting primordial follicles in the ovaries of women with diminished ovarian reserve, in attempt to increase the chance to become pregnant, either naturally or after assisted reproduction.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Biopsy of ovarian cortical tissue
N/A

Detailed Description

For this study investigators will carefully select 20 women with low AMH and imminent POI.

They will be randomized to have cortical ovarian biopsies taken from either the left or right ovary. The biopsies will be fragmented in 1x1 mm2 pieces and immediately auto-transplanted in a peritoneal pocket under the right ovary.

The contralateral untouched ovary will act as the control, making each woman their own control.

Follow up: each week in 2,5 months the women will be assessed by transvaginal ultrasound and hormonal status. After 2,5-6 months the women will receive a FSH stimulation cycle (rFSH 300 IU or Corifollitropin) followed by standard IVF/ICSI,

Hypothesis: the ovaries contain a pool of resting primordial follicles. By fragmentation of cortical ovarian tissue, manipulation of the local environment in the tissue will inhibit the Hippo Pathway and hereby active recruitment and growth of primordial follicles.

Study Design

Study Type:
Interventional
Actual Enrollment :
20 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Investigator)
Primary Purpose:
Treatment
Official Title:
Auto-transplantation of Fragmented Ovarian Cortical Tissue in Infertile Patients With Premature Ovarian Oocyte Depletion - a Study to Promote Follicular Activation and Subsequent Fertility
Study Start Date :
Apr 1, 2016
Actual Primary Completion Date :
Dec 1, 2018
Actual Study Completion Date :
Jan 1, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: Biopsy at Right side

Biopsy of ovarian cortical tissue (50% right side)

Procedure: Biopsy of ovarian cortical tissue
Biopsies will be taken from either right or left side. The cortical tissue will be isolated and fragmented in 1x1 mm2 pieces, followed by auto-transplantation to a peritoneal pocket.

Experimental: Biopsy at Left side

Biopsy of ovarian cortical tissue (50% left side)

Procedure: Biopsy of ovarian cortical tissue
Biopsies will be taken from either right or left side. The cortical tissue will be isolated and fragmented in 1x1 mm2 pieces, followed by auto-transplantation to a peritoneal pocket.

Outcome Measures

Primary Outcome Measures

  1. Number of follicles > 12 mm [Up to 6 month after the auto-transplantation]

    Number of follicles > 12 mm in response to controlled ovarian stimulation with corifollitropin from the biopsied ovary versus the contralateral untreated ovary

Secondary Outcome Measures

  1. Side of ovulation [Up to 6 months after auto-transplantation]

    Frequency of ovulations occurring at the "biopsy side" versus the contralateral side in the subsequent 4- 6 months

Other Outcome Measures

  1. AFC count [Up to 10 month after auto-transplantation]

    Number of antral follicles (AFC) at the biopsy side versus that of the contralateral side

  2. AMH changes [Up up to 10 month after auto-transplantation]

    Changes (increase - decrease) in serum AMH over time, using the highly sensitive new AMH Assay (Elecsys Assay; Roche), which has been implemented as a routine analysis at The Department of Clinical Biochemistry Rigshospitalet in June 1st 2015

  3. Pregnancy [Through study completion, an average of 1 year]

    Numbers of pregnancies (spontaneously/assisted)

Eligibility Criteria

Criteria

Ages Eligible for Study:
25 Years to 39 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Infertility with indication for IVF/ICSI

  • Imminent POI, still cycling

  • Age 25 - 39 years

  • Two ovaries

  • Serum AMH measurements < 5 pmol/l (two independent measurements)

  • Antral follicle count (AFC) (sum of both ovaries < 5)

Exclusion Criteria:
  • Ovarian pathology (endometriosis, cysts)

  • Known chromosomal abnormality

  • Known autoimmune disease (except TPO-antibodies)

  • Patients who have contraindication for laparoscopy

Contacts and Locations

Locations

Site City State Country Postal Code
1 The Fertility Clinic, Rigshospitalet, Copenhagen University Hospital Copenhagen Denmark 2100

Sponsors and Collaborators

  • Anders Nyboe Andersen

Investigators

  • Principal Investigator: Anders N Andersen, Professor, Rigshospitalet, Denmark

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Anders Nyboe Andersen, Professor M.D., Rigshospitalet, Denmark
ClinicalTrials.gov Identifier:
NCT02792569
Other Study ID Numbers:
  • H-15011975
First Posted:
Jun 7, 2016
Last Update Posted:
Jan 30, 2020
Last Verified:
Jan 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Keywords provided by Anders Nyboe Andersen, Professor M.D., Rigshospitalet, Denmark
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 30, 2020